findmyKOL

Jacob Wilensky, MD

Basic profile

University of Illinois Chicago

ORCIDNone on fileNPI↗
✓ Full record
RegionChicago, IL · MidwestSpecialtyOphthalmologyFocusOphthalmology
Last active 2022findmyKOL type: RegionalLatest publication2013Online presenceNot yet checkedPayments2021 onwardNIH funding1985–2000Why? →

Jacob Wilensky is an Ophthalmology physician affiliated with University of Illinois Chicago. OpenAlex indexes 152 publications with 5,901 citations (h-index 42). By OpenAlex citation count, this profile ranks in the top 10% of Ophthalmology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
152publications

Distinct works indexed by OpenAlex.

5,901citations

Total citations across indexed works.

42h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
6NIH grants · 1985–2000

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1740 W Taylor St
Chicago, IL 606127232

Telephone

866-600-2273

Registry record last updated 8 Apr 2009.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    87.6%
    Prostaglandin Analog39.7%
    Latanoprost100%
    Part D≥62 patients
    Carbonic Anhydrase Inhibitor25.7%
    Dorzolamide Hcl52%Dorzolamide-Timolol48%
    Part D≥16 patients

    + 1 more class in this area

  • Cardiovascular

    12.4%
    Beta blocker12.4%
    Timolol Maleate100%
    Part D≥17 patients
Where care is delivered (Part B), 2022100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

6 NIH research awards on record, funded 1985–2000 per NIH RePORTER. The latest:

All 26 award records: search, sort and filter.Explore →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”